Holen Sie sich die Stockscreener-App
4.88
0.20%
-0.010
Handel nachbörslich:
4.83
-0.05
-1.02%
Schlusskurs vom Vortag:
$4.89
Offen:
$5.05
24-Stunden-Volumen:
10,110
Relative Volume:
0.23
Marktkapitalisierung:
$7.26M
Einnahmen:
$59.11M
Nettoeinkommen (Verlust:
$-33.38M
KGV:
-0.0273
EPS:
-178.995
Netto-Cashflow:
$-26.04M
1W Leistung:
+12.21%
1M Leistung:
+34.44%
6M Leistung:
-56.58%
1J Leistung:
-82.62%
1-Tages-Spanne:
$4.615
$5.1799
1-Wochen-Bereich:
$4.02
$5.4499
52-Wochen-Spanne:
$2.5211
$38.52
Dna X Inc Stock (SONM) Company Profile
Firmenname
Dna X Inc
Sektor
Branche
Telefon
650-378-8100
Adresse
4445 EASTGATE MALL, SAN DIEGO, TX
Compare SONM vs MSFT, ORCL, PLTR, CRWD, SNPS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SONM
Dna X Inc
|
4.88 | 7.28M | 59.11M | -33.38M | -26.04M | -179.00 |
MSFT
Microsoft Corp
|
413.62 | 3.08T | 318.27B | 125.22B | 72.92B | 16.79 |
ORCL
Oracle Corp
|
180.29 | 494.19B | 64.08B | 16.40B | -24.74B | 5.5698 |
PLTR
Palantir Technologies Inc
|
146.03 | 345.36B | 4.48B | 1.63B | 2.10B | 0.6328 |
CRWD
Crowdstrike Holdings Inc
|
469.24 | 115.56B | 4.81B | -181.85M | 1.24B | -0.7398 |
SNPS
Synopsys Inc
|
497.50 | 93.68B | 8.00B | 1.10B | 2.28B | 6.4708 |
Dna X Inc Stock (SONM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-10-31 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2019-07-18 | Eingeleitet | B. Riley FBR | Buy |
| 2019-07-09 | Hochstufung | National Securities | Neutral → Buy |
| 2019-06-10 | Eingeleitet | National Securities | Neutral |
| 2019-06-04 | Eingeleitet | Lake Street | Buy |
| 2019-06-04 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Dna X Inc Aktie (SONM) Neueste Nachrichten
How DNA's Double Helix Structure Was Discovered - Britannica
SONM Forecast, Price Target & Analyst Ratings | DNA X INC (NASDAQ:SONM) - ChartMill
[10-K/A] DNA X, Inc. Amends Annual Report - Stock Titan
[8-K] DNA X, Inc. Reports Material Event - Stock Titan
Ginkgo Bioworks will take investor questions after May 7 results - Stock Titan
Ansa Biotechnologies to Showcase Breakthrough DNA Synthesis Technology Backed by Industry’s Only On-Time Guarantee at SynBioBeta 2026 Conference - 01net
Profluent Announces Strategic Partnership with Lilly to Develop AI-Designed Recombinases for Genetic Medicine - Business Wire
SONM Stock Price, Quote & Chart | DNA X INC (NASDAQ:SONM) - ChartMill
SONM Price Today: DNA X, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
INSP (Inspire Medical Systems Inc.) Q4 2025 EPS beats estimates by wide margin even as shares dip slightly today. - Cổng thông tin điện tử tỉnh Lào Cai
SONM (DNA X) tops Q3 2024 EPS forecasts, lifting shares nearly 10 percent on positive investor sentiment.Management Guidance - Cổng thông tin điện tử tỉnh Lào Cai
Sonim Technologies Public Entity Rebrands As DNA X, Inc., A Digital Asset Management Company - 富途牛牛
12 Information Technology Stocks Moving In Wednesday's After-Market Session - Benzinga
DNA X, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
DNA X, Inc. Reports 2025 Financial Results, Completes Asset Sale, and Focuses on Growth of Cryptocurrency Trading Platform - Minichart
DNA X (NASDAQ: SONM) outlines crypto shift, tiny scale and going‑concern risk - Stock Titan
Global Experts Face-to-Face Interview Series – Redefining Yunnan’s Strategic Value - businessnewsthisweek.com
DNA X, Inc. Reports Full Year 2025 Financial Results - Scott Coop
DNA X sold its phone business for $15M to focus on crypto trading - Stock Titan
DNA X (NASDAQ: SONM) narrows 2025 loss and sells mobile unit to fund crypto pivot - Stock Titan
Earnings Report: Will Applied DNA Sciences Inc outperform its industry peersTrade Entry Report & Smart Allocation Stock Reports - baoquankhu1.vn
Restriction-enzyme DNA fingerprinting method explained - Britannica
NexTel Medical Corp Announces Pivotal Milestone in Commercial Launch of Patent-Protected NANOG DNA Cancer Screening Test - The Manila Times
DNA X : News Release - marketscreener.com
Non-controlling/minority interest of DNA X, Inc. – MUN:J6P - TradingView
Power DNA x Lain: Okori enerugî (Music Video 2017)News - IMDb
DNA X, Inc. delays 2025 annual filing - The Globe and Mail
Dna X Inc. Live Share Prices and Trades. SONM.US Live Streaming Share Prices. - London South East
12 Information Technology Stocks Moving In Wednesday's Pre-Market Session - Benzinga
[NT 10-K] DNA X, Inc. SEC Filing - Stock Titan
Ansa Biotechnologies Appoints Matthias Arenskötter as Chief Operating Officer - Business Wire
12 Information Technology Stocks Moving In Monday's Intraday SessionAmplitech Group, Inc.Series A R - Benzinga
Broadbent & Associates, Inc. receives Nevada Gold Mines ‘Results Driven’ DNA award - Northern Nevada Business Weekly
Feel Good Inc. X DNA. (Mashup) [1e740c] - Fathom Journal
DNA X (SONM) Surges 21.9% on Intraday Spike—What’s Behind the Volatility? - Bitget
The latest Star Wars Zero Company details tease Mass Effect DNA, hardcore turn-based tactics, permadeath, and new Clone Wars lore - Eurogamer.net
New liquid biopsy from VolitionRx finds 49 of 49 cancers in early study - Stock Titan
Dna Holdings Venture Inc. Net Worth (2026) - GuruFocus
How The Ginkgo Bioworks (DNA) Story Is Shifting As Analysts Revisit Growth And Risk - Yahoo Finance
Illumina Inc.: Why This DNA Giant Just Got Way More Interesting for You - AD HOC NEWS
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2025 earnings call transcript - MSN
Equity in earnings of DNA X, Inc. – MUN:J6P - TradingView
Hitachi's DNA on Display at Its Birthplace Why the Company's Origin Park Matters as It Globalizes - 東洋経済オンライン
DNA Brands, Inc. (DNAX) Competitors - Meyka
SONM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2025 Earnings Call Transcript - insidermonkey.com
DNA X (NASDAQ: SONM) revises view of DNA X LLC acquisition - Stock Titan
DNA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
How do XX and XY Chromosomes Determine Biological Sex? - Britannica
Software companies need 'innovative DNA' to not just exist, but grow - Yahoo Finance
SONM SEC FilingsDNA X 10-K, 10-Q, 8-K Forms - Stock Titan
Finanzdaten der Dna X Inc-Aktie (SONM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):